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Résumé 
Les rhabdomyomes cardiaques sont des tumeurs cardiaques bénignes avec 
toutefois des complications cardiaques possibles et surtout avec une association 
pour la sclérose tubéreuse de Bourneville qui détermine le pronostic neurologique. 
Cette étude présente une analyse du suivi cardiologique et neurologique à long 
terme d'enfants avec un diagnostic de rhabdomyomes cardiaques dans le but de 
mieux informer les parents lors de la consultation anténatale. 
L'ensemble des cas de rhabdomyomes cardiaques diagnostiqués au moyen de 
l'échocardiographie pendant la période anténatale ainsi que postnatale a été 
répertorié d'août 1982 à septembre 2007. Des facteurs indépendants, tels que le 
nombre et la localisation des tumeurs, ont été analysés pour leur association avec le 
diagnostic de la sclérose tubéreuse de Bourneville, afin de prédire le pronostic 
cardiaque et neurologique de ces patients. 
Les complications cardiaques retrouvées sont les arythmies, les obstructions des 
voies d'éjection ventriculaire et le choc cardiogène secondaire. Les arythmies sont 
les problèmes les plus fréquemment rencontrés pendant la période néonatale. La 
tachycardie supraventriculaire est le trouble de rythme le plus souvent identifié. 
Néanmoins, il n'y a pas de dimension ou de localisation spécifique d'un 
rhabdomyome cardiaque qui pourrait prédire ces troubles du rythme. 
L'importance de l'association au diagnostic de la sclérose tubéreuse de Bourneville 
chez les patients atteints de rhabdomyomes est démontrée à travers les 
complications du développement neurologique avec une atteinte épileptique dans 
80% des cas ainsi qu'un retard de développement dans 63% des cas. 
La présence de multiples tumeurs cardiaques chez un patient suggère un risque 
accru d'être atteint de la sclérose tubéreuse de Bourneville comparé à un patient 
atteint d'une tumeur unique. 
Les rhabdomyomes cardiaques régressent après la naissance et après la période 
périnatale les complications cardiaques deviennent rares. Toutefois, l'association à la 
sclérose tubéreuse de Bourneville domine le tableau clinique avec des complications 
au niveau du développement neurologique et forme donc un aspect important lors de 
la consultation anténatale. 
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Abstract 
Cardiac rhabdomyomas are benign cardiac tumors with few cardiac complications 
but with a known association to tuberous sclerosis that affects the neurologie 
outcome of the patients. 
This study analyses the long-term cardiac and neurological outcome of patients with 
cardiac rhabdomyomas in order to allow comprehensive prenatal counseling. 
Ali prenatal and postnatal cases with echocardiographic diagnosis of cardiac 
rhabdomyomas encountered from August 1982 - September 2007 have been 
recorded. lndependent factors, such as the number and the location of the tumors, 
have been analyzed for association with a diagnosis of tuberous sclerosis, in order to 
predict the cardiac and neurologie outcome of the patients. 
Cardiac complications include arrhythmias, outflow tract obstruction, secondary 
cardiogenic shock. Arrhythmias are the most often encountered problems during the 
neonatal period. Supraventricular tachycardia is the commonest rhythm disturbance 
identified. However, no specific dimension or location of the cardiac rhabdomyomas 
may predict the rhythm disturbances. 
The importance of the diagnosis of tuberous sclerosis in patients presenting with 
cardiac rhabdomyomas is exemplified by the neurodevelopmental complications 
showing 80% of cases with epilepsy and 63% of cases with a delayed development. 
The presence of multiple cardiac tumors in patients suggests a higher risk to be 
affected by tuberous sclerosis, compared to patients with a single tumor. 
Cardiac rhabdomyomas generally regress after birth and after the perinatal period 
cardiac-related problems are rare, but tuberous sclerosis and the associated 
neurodevelopmental complications dominate the clinical picture and should form an 
important aspect of the prenatal counseling of parents. 
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1. Introduction 
The diagnosis of cardiac rhabdomyomas can either be prenatal, as an incidental 
finding in the fetal cardiology clinic or may be a finding in the postnatal work-up for 
tuberous sclerosis. Cardiac tumors are rare, the incidence of the primary tumors of 
the heart and pericardium, reported from autopsy studies of patients of all ages, 
varies from 0.17 to 28 in 1 O'OOOi. ln children, the most frequent histological types are 
rhabdomyomas (60%), teratomas (25%) and fibromas (12%). The in-utero course 
depends on the growth and on the size of the tumors. Large masses can cause 
hemodynamic obstruction and subsequent heart failure, as well as fetal hydrops or 
tachyarrhythmia.2-7 While these life threatening complications in the perinatal period 
are relatively rare, cardiac complications such as rhythm disturbances as well as the 
association with tuberous sclerosis8 represent the crucial point for the long-term 
outcome.9 Cardiac rhabdomyomas are reported to be associated with tuberous 
sclerosis in approximately 50% to 86% of patients 10, 11 and up to 80% of patients with 
tuberous sclerosis have cardiac rhabdomyomas.12 Therefore, the association to 
tuberous sclerosis should form an important issue during the prenatal counseling of 
parents. The aim of this study is to analyze the data of patients with cardiac 
rhabdomyomas and their long-term cardiac and neurological outcome in order to 
allow comprehensive prenatal counseling. 
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2. Methods 
This multi-center retrospective study was performed on the data of all patients with 
echocardiographic diagnosis of cardiac rhabdomyoma encountered at our institutions 
from August 1982 to September 2007. The criteria for the diagnosis of 
rhabdomyomas included the demonstration of the presence of multiple intracardiac 
tumors with characteristic echocardiographic appearance, in the absence of known 
malignant disease or existence of one or more tumors in association with tuberous 
sclerosis. These criteria were based on the information that fibromas and myxomas 
are invariably solitary tumors and on the very strong association between 
rhabdomyomas and tuberous sclerosis. A further and most important criterion was 
the evolution of the tumors, which is their tendency to regress and disappear in time. 
The patients with a prenatal diagnosis had been referred for fetal echocardiography 
due to a suspicion of a cardiac anomaly on obstetrical ultrasound. The patients with 
postnatal diagnosis were referred either for cardiac tumor detection in the presence 
of otherwise proven tuberous sclerosis or were investigated for cardiac symptoms 
like a murmur due or rhythm disturbance in an otherwise healthy child. 
The patients were followed up by the mean of echocardiography over 3 months to 18 
years (with a mean time period of 4.8 years). The age at the cardiac rhabdomyoma 
detection, the number and the size of nodules at the time of detection were 
documented, together with their evolution on follow-up echocardiography and 
associated cardiac complications. 
A review of the medical records all the cases with cardiac rhabdomyoma researching 
the major criteria for the diagnosis of tuberous sclerosis (central nervous system 
findings, skin findings, renal angiomyofibromas and retinal harmatomas) was carried 
out. The incidence of tuberous sclerosis was documented and its association to the 
number of tumors and their exact cardiac location statistically studied. The 
hypothesis was that certain locations are more likely to be related to tuberous 
sclerosis than others. The potential association to the number of the tumors was 
analyzed by using Fisher's exact test with results presented as p-value and Odd's 
ratio for 95% confidence intervals. 
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ln the subgroup with precise neurological follow-up the neurodevelopmental 
complications were documented in terms of the presence of epilepsy, its contrai, the 
number of anti-epileptic drugs required the presence of developmental delay, 
requirement for special school and any associated behavioral issues. The 
assessment of the severity of the developmental delay (mild, moderate, severe) was 
based on the developmental evaluation by pediatric neurologists. 
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3. Results 
The present study deals with 73 patients with a finding of cardiac rhabdomyoma. 
Among these cases, 20 patients were diagnosed in-utero at a gestational age 
between 20 and 35 weeks and 53 patients postnatally between 10 days and 11 
years. 
3.1 Number and location of cardiac rhabdomyomas 
70% of the patients (51) presented with multiple cardiac rhabdomyomas while 30% of 
the patients (22) had a single tumor. Table 1 shows the association between the 
presence of multiple cardiac rhabdomyomas and the incidence of tuberous sclerosis. 
4 of 73 patients had no follow up and are therefore not reported in Table 1. Tuberous 
sclerosis was diagnosed in 42 patients (86%) with multiple cardiac rhabdomyomas 
and in 13 patients (65%) with a single rhabdomyoma (p value 0.095; Odds Ratio 
3.17; confidence interval at 95% of the odds ratio 0.79 to 12.92). 
Tuberous sclerosis + Tuberous sclerosis - Total 
Multiple tumors 42 7 49 
Single tumor 13 7 20 
Total 55 14 69 
Fisher's exact test: p value 0.095; Odd's ratio 3.17; Cl at 95% Odd's ratio 0.79 to 
12.92 
Table 1 - Presence of multiple cardiac rhabdomyomas related to the incidence of 
tuberous sclerosis 
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The tumors were predominantly located in the left ventricle, 74% of the patients 
presented at least one tumor at this site. 48% of the patients had at least one tumor 
in the right ventricle, 44% in the interventricular septum, and a few patients had 
tumors in the atria (right atrium 8% and left atrium 1 %), in the interatrial septum (5%) 
and in the pericardium (1 %). 
Table 2 gives the relation between these different locations and the presence of 
tuberous sclerosis (relative risk). The values are given in terms of numbers of 
patients (with and without a diagnosis of tuberous sclerosis) presenting at least one 
tumor in the specific locations. 
Relative risk 
patients TS + patients TS - ( estimated error) 
Left ventricle 44 8 5.5 (0.6) 
lnterventricular septum 26 6 4.3 (0.6) 
Right ventricle 30 3 10.0 (2.5) 
Right atrium 5 1 5.0 (2.5) 
lnteratrial septum 5 1 5.0 (2.5) 
Left atrium 1 0 
Pericardium 1 0 
TS = tuberous sclerosis 
Relative risk = n(TS+) / n(TS-), estimated error for n(TS-) + 1. 
Table 2 - Location of the cardiac rhabdomyomas in patients with tuberous sclerosis 
and in patients without diagnosis of tuberous sclerosis 
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3.2 Size and evolution of cardiac rhabdomyomas 
The diameter of the tumors in the prenatal group at diagnosis ranged from 1 to 37 
millimeters and in the postnatal group from 2 to 55 millimeters. Figure 1 shows the 
fetal and postnatal echocardiography of one of the patients. 
ln the group diagnosed positive for tuberous sclerosis the tumors ranged from 1 to 55 
millimeters in size, versus 2 to 30 millimeters for the group not affected by tuberous 
scie rosis. 
Postnatal regression of the number and/or size of nodules was observed for 74% of 
patients (40) who had follow-up echocardiographic data (54). Complete resolution of 
cardiac rhabdomyoma was documented in 28% patients (15), and partial resolution in 
46% patients (25), 19% (10) showing no changes in the tumors. ln four cases 
nodules increased in size and new masses appeared over 6 to 14 years. Among 15 
patients showing complete resolution by 6 months to 1 O years of age respectively, 12 
belonged to the postnatal group and 11 patients had been diagnosed for tuberous 
sclerosis. 
. A number of 6 patients showed partial resolution of big nodules along with complete 
resolution of smaller nodules in a time period of 1-11 years follow-up. The remaining 
cases demonstrated partial resolution of the rhabdomyomas or no changes of the 
nodules in a time period of 1-18 years follow up. 
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a) b) 
Legends: A: anterior, LV: left ventricle, RV: right ventricle, R: right 
Figure 1 - Fetal and postnatal cardiac rhabdomyoma: a) Fetal echocardiogram at 35 
weeks of gestation and b) transthoracic echocardiogram at 2 weeks of age. 
Note: The two 4-chamber views show a huge rhabdomyoma in the free 
wall of the right ventricle (arrowhead) and smaller rhabdomyomas in the 
interventricular septum (stars) and in the free wall of the left ventricle 
(arrows). 
3.3 Cardiac complications 
Cardiac follow up by echocardiography was carried out for 53 patients from this 
population of 73 patients. These investigations showed that cardiac complications 
were encountered in 23% of cases and 2 of them required immediate intervention 
during the neonatal period. The first patient diagnosed with multiple cardiac 
rhabdomyoma at 34 weeks of gestational age was delivered by elective Caesarean 
section at 37 weeks due to significant left ventricular outflow tract obstruction by one 
of the nodules with a pressure gradient of almost 50 mmHg by Doppler between 
Aorta and LV. Successful surgical removal of the obstructing nodule was performed 
in the neonatal period. The second patient diagnosed with multiple cardiac 
rhabdomyoma at 28 weeks gestational age was delivered uneventfully but had Wolf-
Parkinson-White Syndrome with refractory supraventricular tachycardia for 3 weeks 
after birth requiring anti-arrhythmic treatment and is currently stable under therapy. 7 
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other patients had rhythm disturbances, 5 in the form of occasional paroxysmal 
supraventricular tachycardia with or without Wolf-Parkinson-White syndrome in 
infancy, but were stable clinically and did not warrant any intervention, one had 
ventricular arrhythmia. Surgery with excision of the tumor was required in 2 patients, 
one with had sub-aortic obstruction and one with pulmonary outflow obstruction. One 
patient died at 22 days of age of cardiogenic shock due to obstruction of left 
ventricular filling caused by a tumor in the left ventricle (size 30x30millimeters). 
No specific dimension or location of the cardiac rhabdomyoma could predict the 
above reported rhythm disturbances. 
3.4 Neurodevelopmental complications 
Tuberous sclerosis was a definite diagnosis in 76% of cases (55 patients) as they 
fulfilled 2 or more of the major criteria 13 for tuberous sclerosis diagnosis. Of the 55 
cases with tuberous sclerosis, 20% of cases (11) did not have epilepsy whereas 80% 
(44) had epilepsy (Figure 2). Among those with epilepsy 32 patients had a precise 
neurological follow up which showed that, 6% of cases (2) are off antiepileptic drugs 
as they had a long seizure-free interval, 56% of cases (18) have well to moderate 
contrai (occasional seizure) on 1-2 antiepileptic drugs and 38% (12) have refractory 
epilepsy (several seizures per week). One patient who had pharmaco-resistent 
epilepsy in infancy underwent seizure surgery at 14 months of age and currently has 
moderately controlled epilepsy with 2 antiepileptic drugs. 
Developmental delay was seen in 68% of cases (36) with tuberous sclerosis while 
32% of cases (17) developed normally. Among the patients with developmental delay 
25 had a follow up: 56% (14) had mild delay, 32% (8) had moderate delay and 12% 
(3) had severe delay. ln terms of academic performance, 60% of the developmentally 
delayed patients (15) are in special schools, 20% (5) are in regular schools with extra 
support for academic work and 20% (5) are young patients not yet in school. 
Behavioral problems in the form of reduced attention span, aggressiveness, 
hyperactivity, impatience and mood fluctuations were encountered in 22% of patients 
(8) with developmental delay of which one patient was documented to have autism 
(1.8% of TS cases). 
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Oevelopmental delay 
36 
developmental delay 
15 
special school 
5 
regular school 
5 
under school age 
11 
no followup 
53 
patients 
17 
normal development 
11 
no epilepsy 
Epilepsy 
55 
patients 
44 
epilepsy 
18 
controlled under AED 
7 
refractory epilepsy 
2 
seizure free 
17 
no follow up 
Figure 2 - Neurodevelopmental issues in patients with tuberous sclerosis 
AED - antiepileptic drugs 
3.5 Other findings 
A major involvement of other organ systems not in relation to TS was noted in 3% of 
cases (2) in the series, one patient had dysmorphism with multiple organ involvement 
and another patient had nephroblastoma stage 4S requiring surgery with left 
nephrectomy in infancy. 
13 
4. Discussion 
As described in the literature, the cardiac rhabdomyomas in this series of patients 
were benign. They showed spontaneous regression in most of the cases 14-20 and 
appeared between 20 and 30 weeks gestational age in any part of the heart. 
The main growth of the tumors occurred between the second and the third trimester, 
as well as during the early postnatal period. 
During prenatal lite, the tumors in this population were clinically silent but intrauterine 
death has been reported 21, 22 mostly following fetal arrhythmia and hydrops. 
Among the various cardiac complications, arrhythmias were the most often 
encountered problems23-27 during the neonatal period. Supraventricular tachycardia is 
the commonest rhythm disturbance identified, such as in our series. Bradycardia, 
heart block and pre-excitation syndromes are the other arrhythmias reported.28, 29 
Arrhythmias were predominantly treatable by vagal maneuver, pharmaco-therapeutic 
intervention, radio-frequency ablation and/or cardioversion. Rarely the arrhythmias 
caused mortality. 
By analyzing the size and location of the tumors in patients with arrhythmia compared 
to patients without rhythm disturbances, it can be concluded, that there is no specific 
size or location of the tumor that can predict this particular complication. 
Further cardiac complications in this series included development of intra-cardiac 
flow obstruction, alteration of the atrio-ventricular valve function with consequent 
regurgitation, cardiac dysfunction and hydrops. Large left ventricular tumors can lead 
to severe left ventricular outflow tract obstruction in some patients, warranting 
surgical excision3o, 31. Further they can very rarely cause uni-ventricular physiology in 
infants and pose a difficult management problem32. The hemodynamic complications 
encountered in late fetal lite can be minimized by performing well timed preterm 
induced delivery or caesarean section. Surgery is the treatment of severe 
hemodynamic complications, arrhythmias or other primary cardiac tumors.33, 34, 35 
As in this population the natural history of cardiac rhabdomyomas after birth is 
dominated by the neurological impairment due to tuberous sclerosis. As shown by 
Tworetzky et ais, these cardiac tumors are frequently associated to tuberous 
sclerosis. 
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The importance of the diagnosis of tuberous sclerosis in a patient presenting with 
cardiac rhabdomyoma is exemplified in our results of neurodevelopmental 
complications. The results show that 80% of cases are affected by epilepsy and 63% 
of cases have a delayed development, data which are in accordance with the data 
mentioned in larger demographic series36 for patients affected by tuberous sclerosis, 
reporting that 80% have epilepsy and 44-82% have neurodevelopmental difficulties. 
lt is important to point out that most of the patients with epilepsy have a good to 
moderate contrai of the seizure on antiepileptic drugs. Nevertheless 38% of epileptic 
patients have refractory epilepsy. 
These results form an important issue during the prenatal counseling of parents 
about the further neurological and psychosocial development of their child. 
On the basis of a statistical test (Fisher's exact test) and in order to enhance the 
predictions for the parents during the prenatal counseling, about the risks of 
developing tuberous sclerosis, the following statements are important to be 
mentioned. lt must however be realized that this study although encompassing a 
large series on this subject, carries ail the limitations of a retrospective study. 
The presence of multiple cardiac tumors in patients suggests a risk factor of 6 to be 
affected by tuberous sclerosis. This fact has already been observed on an other 
population by Tworetzky et af> , but they found a substantially higher risk factor(20) 
than we in our series. The risk analyses for single cardiac tumors diverge even more, 
we found a risk factor of 1.9 to be affected by tuberous sclerosis in case of a single 
tumor, while Tworetzky et a/found a factor of 0.33. This divergence could be due to a 
difference in the two studied populations, we excluded all other primary cardiac 
tumors than rhabdomyomas whereas Tworetzky et al included other primary tumors 
in the group of patients presenting with a single tumors. lt is therefore extremely 
important to differentiate the primary tumors (rhabdomyomas, teratomas, fibromas 
and myxomas) during the prenatal counselling since they have a different impact on 
the neurological outcome related to tuberous sclerosis. 
Furthermore, it can be observed that the sizes of tumors in patients affected by 
tuberous sclerosis are slightly bigger. ln this population, tumors with a size bigger 
than 30millimetres were only observed in patients with tuberous sclerosis. Additional 
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research should be performed to conclude in a more definitive way if the size of the 
tu mors may be a relevant factor in the diagnosis of tuberous sclerosis. 
By analyzing the incidence of cardiac rhabdomyoma at different location related to 
the presence of tuberous sclerosis, we can conclude that there is no straightforward 
relationship between any of the locations and tuberous sclerosis (Table 2). 
The comparison of the data between the prenatal and the postnatal group shows in 
effect no significant difference between the size, the cardiac complications and the 
development of tuberous sclerosis. 
Tuberous sclerosis is an autosomal dominant Mendelian condition with a large 
variability of expression and a 50% familial occurrence. Chen et al 37 reported on 2 
families with prenatally diagnosed cardiac rhabdomyomas and subsequently 
confirmed tuberous sclerosis with molecular genetic analysis. We only recently 
embarked on testing our patients genetically, with so far 3 positive outcomes. This 
should support the opinion that this condition should be suspected in all children with 
prenatally diagnosed cardiac rhabomyomas. Therefore, genetic testing should be 
applied in ail patients with these cardiac tumors. Prenatal genetic analysis (of index 
patient and the parents to exclude polymorphism) can be considered to enable early 
implementation of further diagnostic evaluation and genetic counseling.3s although 
the sensitivity of this technique is not yet completely elucidated. Recently, Milunsky et 
al 39 have performed prenatal genetic analysis of a fetus with cardiac rhabdomyomas 
to confirm the diagnosis of tuberous sclerosis. 
However, precise prenatal molecular diagnosis of tuberous sclerosis has been not 
been realized yet. As long as we don't have a reliable genetic testing, the risk-
calculations should be helpful for the prenatal counselling. Genetie testing should 
. particularly be performed for prenatal diagnosis in subsequent pregnancies, if after 
having had an affected child bath parents prove negative for TSC1 and TSC2 
mutations on sequencing. 
Limitations: This study included all the limitations of a retrospective study, which 
prevented a more concise way of reporting. 
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5. Conclusion 
This study approaches a rare problem with potential perinatal and early infancy 
cardiac impact and long term neurologie sequelae, which importance is located in 
the numbers of cases, and not so much in the separation in to pre and post natal 
diagnosis.On the basis of this large population, it can be concluded that cardiac 
rhabdomyomas generally regress with time and surgical and/or pharmacological 
interventions are rarely required. Arrhythmias exist and may rarely be fatal but once 
adequately treated, they play a minor role in the overall outcome of the patients. The 
constant association of cardiac rhabdomyomas with tuberous sclerosis and the 
associated neurological impact however is clearly the dominating aspect in the long-
term outcome and quality of life in these patients and hence calls for prenatal genetic 
testing and comprehensive prenatal counseling of parents whose fetuses are 
diagnosed with this rare disease. 
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